UDICARE 600 SR

MRP
780/Strip

Description
Each uncoated sustained release tablet contains Ursodeoxycholic Acid IP 600 mg.

Doses
As Directed by physician

Indication
Ursodeoxycholic acid is indicated in the treatment of primary biliary cirrhosis (PBC) and for the dissolution of radiolucent gallstones in patients with a functioning gall bladder. It is also used for hepatobiliary disorders associated with cystic fibrosis in children aged 6 to 18 years.